127 related articles for article (PubMed ID: 8606245)
1. Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb.
Neumann DR; Basile KE; Bravo EL; Chen EQ; Go RT
J Comput Assist Tomogr; 1996; 20(2):312-6. PubMed ID: 8606245
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of early cancer with positron emission tomography].
Kubota K
Nihon Rinsho; 1996 May; 54(5):1263-7. PubMed ID: 8965348
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of primary mediastinal tumours.
Kubota K; Yamada S; Kondo T; Yamada K; Fukuda H; Fujiwara T; Ito M; Ido T
Br J Cancer; 1996 Apr; 73(7):882-6. PubMed ID: 8611400
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
Shulkin BL; Koeppe RA; Francis IR; Deeb GM; Lloyd RV; Thompson NW
Radiology; 1993 Mar; 186(3):711-5. PubMed ID: 8430179
[TBL] [Abstract][Full Text] [Related]
7. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
Proli C; De Sousa P; Jordan S; Anikin V; Devaraj A; Love SM; Shackcloth M; Kostoulas N; Papagiannopoulos K; Haqzad Y; Loubani M; Sellitri F; Granato F; Bush A; Marchbank A; Iyer S; Scarci M; Lim E;
BMJ Open; 2018 Feb; 8(2):e019471. PubMed ID: 29437755
[TBL] [Abstract][Full Text] [Related]
8. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
9. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
10. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.
Camici P; Araujo LI; Spinks T; Lammertsma AA; Kaski JC; Shea MJ; Selwyn AP; Jones T; Maseri A
Circulation; 1986 Jul; 74(1):81-8. PubMed ID: 3486725
[TBL] [Abstract][Full Text] [Related]
11. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
12. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Smith SM; Young CS; Bishop AF
AJR Am J Roentgenol; 1996 Nov; 167(5):1153-4. PubMed ID: 8911171
[No Abstract] [Full Text] [Related]
14. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
[TBL] [Abstract][Full Text] [Related]
15. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
[TBL] [Abstract][Full Text] [Related]
16. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
Nettelbladt OS; Sundin AE; Valind SO; Gustafsson GR; Lamberg K; Långström B; Björnsson EH
J Nucl Med; 1998 Apr; 39(4):640-7. PubMed ID: 9544671
[TBL] [Abstract][Full Text] [Related]
17. Quantitative metabolic PET imaging of a plasma cell granuloma.
Slosman DO; Spiliopoulos A; Keller A; Lemoine R; Besse F; Couson F; Townsend D; Rochat T
J Thorac Imaging; 1994; 9(2):116-9. PubMed ID: 8207776
[TBL] [Abstract][Full Text] [Related]
18. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
19. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Scott WJ; Gobar LS; Hauser LG; Sunderland JJ; Dewan NA; Sugimoto JT
Chest; 1995 Apr; 107(4):1174-6. PubMed ID: 7705136
[TBL] [Abstract][Full Text] [Related]
20. PET scanning said to save money and improve staging of lung cancer.
Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
